Tilray Brands (TLRY) Change in Cash (2017 - 2026)
Tilray Brands' (TLRY) quarterly Change in Cash came in at -$20.2 million in Q2 2026, down 192.87% YoY from $21.7 million in Q2 2025, and down 819.59% on a QoQ basis from $2.8 million in Q1 2026.
Tilray Brands (TLRY) Change in Cash (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Change in Cash data on file, last reported at -$20.2 million in Q2 2026.
- Quarterly Change in Cash fell 192.87% year-over-year to -$20.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $7.7 million (up 215.01% YoY) and the FY2026 annual result came in at $7.7 million, up 215.01% from the prior year.
- Change in Cash retreated to -$20.2 million in Q2 2026, from $2.8 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $136.7 million in Q2 2022 to a low of -$300.4 million in Q4 2022.
- A 5-year average of -$5.7 million and a median of -$7.1 million in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 574.9% — and 2025, when it surged 686.66%.
- Tracing TLRY's Change in Cash over 5 years: stood at -$300.4 million in 2022, then surged by 88.62% to -$34.2 million in 2023, then jumped by 54.69% to -$15.5 million in 2024, then retreated by 17.03% to -$18.1 million in 2025, then dropped by 11.24% to -$20.2 million in 2026.
- The last three Change in Cash figures came in at -$20.2 million (Q2 2026), $2.8 million (Q1 2026), and -$18.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | -20.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -20.16 Mn |
| Feb 28, 2026 | 2.80 Mn |
| Nov 30, 2025 | -18.13 Mn |
| Aug 31, 2025 | 43.16 Mn |
| May 31, 2025 | 21.71 Mn |
| Feb 28, 2025 | 10.26 Mn |
| Nov 30, 2024 | -15.49 Mn |
| Aug 31, 2024 | -23.15 Mn |
| May 31, 2024 | 82.09 Mn |
| Feb 29, 2024 | 1.30 Mn |
| Nov 30, 2023 | -34.18 Mn |
| Aug 31, 2023 | -27.50 Mn |
| May 31, 2023 | 41.64 Mn |
| Feb 28, 2023 | -25.22 Mn |
| Nov 30, 2022 | -300.43 Mn |
| Aug 31, 2022 | 74.73 Mn |
| May 31, 2022 | 136.70 Mn |
| Feb 28, 2022 | -52.57 Mn |
| Nov 30, 2021 | -44.51 Mn |
| Aug 31, 2021 | -112.17 Mn |